Jill Bertotti News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jill Bertotti. Real-time updates on events, politics, business and more.

Magenta Therapeutics Presents Positive MGTA-117 Clinical

December 12, 2022

– MGTA-117 preliminary clinical results from 15 patients across three dose-escalation cohorts of the ongoing Phase 1/2 clinical trial shows single-agent...

United Kingdom United States Jill Bertotti Jason Gardner Exchange Commission American Society Of Hematology

Source: globenewswire.com

Magenta Therapeutics Reports Third Quarter Financial Results and Recent Program Highlights

November 3, 2022

– New clinical results from ongoing MGTA-117 Phase 1/2 clinical trial support earlier observations of target binding, target cell depletion, rapid drug clearance and a favorable tolerability... | November 3, 2022

United Kingdom United States Jill Bertotti Jason Gardner Magenta Therapeutics Inc Good Laboratory Practices

Source: marketscreener.com

Magenta Therapeutics Appoints Michael Vasconcelles, M.D. to the Board of Directors

August 17, 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United Kingdom Dana Farber Cancer Institute United States Michael Vasconcelles Jill Bertotti Mike Vasconcelles

Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Jill Bertotti News Today

Magenta Therapeutics Presents Positive MGTA-117 Clinical

Magenta Therapeutics Reports Third Quarter Financial Results and Recent Program Highlights

Magenta Therapeutics Appoints Michael Vasconcelles, M.D. to the Board of Directors

Explore More Categories